Significant coronary artery disease detected by amyl nitrite and systolic time intervals
Insights
Amyl nitrite (AN) inhalation effectively differentiates coronary artery disease (CAD) severity by analyzing left ventricular systolic time intervals. A significant change in the ejection time/preejection period ratio indicates normal coronary arteries, aiding in CAD diagnosis.
Area of Science:
- Cardiology
- Diagnostic Medicine
- Physiology
Background:
- Coronary artery disease (CAD) diagnosis relies on invasive procedures.
- Non-invasive methods for assessing CAD severity are crucial.
- Systolic time intervals reflect left ventricular function.
Purpose of the Study:
- To evaluate the relationship between amyl nitrite (AN)-induced changes in left ventricular systolic time intervals and CAD severity.
- To determine the diagnostic utility of the AN inhalation test for detecting significant CAD.
Main Methods:
- Seventy-seven patients undergoing cardiac catheterization were studied.
- Left ventricular systolic time intervals, including ejection time (ET) and preejection period (PEP), were measured before and after AN inhalation.
- Changes in ET/PEP ratio and left ventricular dP/dt were analyzed in relation to CAD presence and severity.
Main Results:
- In control subjects, AN inhalation significantly increased ET and the ET/PEP ratio.
- Patients with CAD showed insignificant changes in ET/PEP after AN inhalation.
- A less than 30% increase in ET/PEP with AN inhalation detected significant CAD with 92% sensitivity and 84% specificity.
Conclusions:
- Amyl nitrite inhalation significantly alters systolic time intervals in healthy individuals but not in patients with CAD.
- The AN inhalation test is a safe, simple, and effective stress test for evaluating the presence and severity of significant CAD.
- The degree of CAD influences the response to AN, suggesting factors beyond pump function are involved.
Abstract:
The relation between changes in left ventricular systolic time intervals with amyl nitrite (AN) inhalation and the severity of coronary artery disease (CAD) was evaluated in 77 patients who underwent catheterization because of chest pain. In 25 subjects with normal coronary angiograms (control group), AN inhalation increased the ejection time (ET), shortened the preejection period (PEP) and increased the ET/PEP markedly. In the 52 patients with CAD (CAD group), the ET/PEP changed insignificantly after AN. The difference between the 2 groups was significant (p less than 0.001). At cardiac catheterization, the increase of left ventricular dP/dt after AN in the control group was significantly larger than that in the CAD group. Although a positive correlation between changes in ET/PEP with AN and ejection fraction at rest was noted in patients with 1-vessel CAD, no such correlation was noted in those with multivessel CAD. This suggests that factors in addition to pump function, such as the degree of CAD, influence the effect of AN inhalation on systolic time intervals. When an increase of less than 30% in ET/PEP occurs with AN inhalation, the presence of significant CAD can be detected with a sensitivity of 92%, a specificity of 84% and the predictive value of 92%. The AN inhalation test is safe and simple, and thus could serve as a stress test for evaluating the presence and severity of significant CAD.
Related Concept Videos
Coronary Artery Disease III: Clinical Manifestations
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome III: Diagnostic Studies
Angina II: Classification
Angina III: Clinical Manifestations and Assessment


